Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Blood|December 4, 2010
Long-term use of vitamin K antagonists and incidence of cancer: a population-based studyVittorio Pengo, Franco Noventa, Gentian Denas, et al.
Clinical Chemistry and Laboratory Medicine|April 1, 2024
Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrenceVittorio Pengo, Luca Sarti, Emilia Antonucci, et al.
Cardiovascular Therapeutics|October 28, 2017
Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA<sub>2</sub> DS<sub>2</sub> VASc 1 or 2): A treatment dilemmaGentian Denas, Giacomo Zoppellaro, Seena Padayattil Jose, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 27, 2019
Mechanisms of recurrent regurgitation after transapical off-pump mitral valve repair with neochord implantation†Andrea Colli, Laura Besola, Eleonora Bizzotto, et al.
Thescientificworldjournal|November 7, 2014
An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditionsGiacomo Emmi, Elena Silvestri, Danilo Squatrito, et al.
International Journal of Cardiology|September 23, 2017
Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naïve patients with non-valvular atrial fibrillation: Propensity score matched cohort studyGentian Denas, Nicola Gennaro, Eliana Ferroni, et al.
Thrombosis and Haemostasis|June 22, 2019
Antiphospholipid Syndrome in Chronic Thromboembolic Pulmonary Hypertension: A Well-Defined Subgroup of PatientsXin Jiang, Yao Du, Chun-Yan Cheng, et al.
Internal and Emergency Medicine|April 22, 2015
To treat or not to treat very elderly naïve patients with atrial fibrillation with vitamin K antagonists (VKA): results from the VENPAF cohortSerena Granziera, Giulia Bertozzo, Vittorio Pengo, et al.
Thrombosis Research|December 3, 2014
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulantVittorio Pengo, Sophie Testa, Ida Martinelli, et al.
Rheumatology (Oxford, England)|April 12, 2022
Impact of COVID-19 and COVID-19 vaccination on high-risk patients with antiphospholipid syndrome: a nationwide surveyVittorio Pengo, Teresa Del Ross, Marta Tonello, et al.
Pageof 6